What is the future of telomere length testing in telomere biology disorders?

References

• Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20(5):299–309.
   PubMed Web of Science ®Google Scholar
• Mitchell J R, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402(6761):551–5. DOI:10.1038/990141
   PubMed Web of Science ®Google Scholar
• Heiss N S, Knight S W, Vulliamy T J, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19(1): 32–8. DOI:10.1038/ng0598-32
   PubMed Web of Science ®Google Scholar
• Niewisch MR, Giri N, McReynolds LJ, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022;139(12):1807–1819. DOI:10.1182/blood.2021013523
   PubMed Web of Science ®Google Scholar
• Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nat Rev Genet. 2022;24(2):86–108.
   PubMed Web of Science ®Google Scholar
• Tummala H, Walne A, Dokal I. The biology and management of dyskeratosis congenita and related disorders of telomeres. Expert Rev Hematol. 2022;15(8):685–696.
   PubMed Web of Science ®Google Scholar
• Lai TP, Wright WE, Shay JW. Comparison of telomere length measurement methods. Philos Trans R Soc Lond B Biol Sci. 2018;373(1741):20160451.
   PubMed Web of Science ®Google Scholar
• Aviv A, Hunt SC, Lin J, et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res. 2011;39(20):e134.
   PubMed Web of Science ®Google Scholar
• Khincha PP, Dagnall CL, Hicks B, et al. Correlation of leukocyte telomere length measurement methods in patients with dyskeratosis congenita and in their unaffected relatives. Int J Mol Sci. 2017;18(8):1765. DOI:10.3390/ijms18081765
   PubMed Web of Science ®Google Scholar
• Gutierrez-Rodrigues F, Santana-Lemos BA, Scheucher PS, et al. Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS ONE. 2014;9(11):e113747.
   PubMed Web of Science ®Google Scholar
• Baerlocher GM, Mak J, Tien T, et al. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47(2):89–99.
   PubMedGoogle Scholar
• Savage SA, Giri N, Baerlocher GM, et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008;82(2):501–509.
   PubMed Web of Science ®Google Scholar
• Alder JK, Hanumanthu VS, Strong MA, et al. Diagnostic utility of telomere length testing in a hospital-based setting. Proc Natl Acad Sci U S A. 2018;115(10):E2358–2365. DOI:10.1073/pnas.1720427115
   PubMed Web of Science ®Google Scholar
• Alter BP, Rosenberg PS, Giri N, et al. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica. 2012;97(3):353–359.
   PubMed Web of Science ®Google Scholar
• Alter BP, Baerlocher G, Savage SA, et al. Telomere length measurement by flow-FISH distinguishes Dyskeratosis congenita from other bone marrow failure syndromes. Blood. 2006;108(11):58A–59A. DOI:10.1182/blood.V108.11.183.183
   Web of Science ®Google Scholar
• Savage SA. Dyskeratosis congenita and telomere biology disorders. Hematology Am Soc Hematol Educ Program. 2022;2022(1):637–648.
   PubMedGoogle Scholar
• Mighton C, Shickh S, Uleryk E, et al. Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Med. 2021;23(1):22–33.
   PubMed Web of Science ®Google Scholar
• Tummala H, Walne A, Buccafusca R, et al. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. Am J Hum Genet. 2022;109(8):1472–1483. DOI:10.1016/j.ajhg.2022.06.014
   PubMed Web of Science ®Google Scholar
• Richards CS, Bale S, Bellissimo DB, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med. 2008;10(4):294–300. DOI:10.1097/GIM.0b013e31816b5cae
   PubMed Web of Science ®Google Scholar
• Norris K, Walne AJ, Ponsford MJ, et al. High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders. Hum Genet. 2021;140(6):945–955. DOI:10.1007/s00439-021-02257-4
   PubMed Web of Science ®Google Scholar
• Hemann MT, Strong MA, Hao LY, et al. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107(1):67–77.
   PubMed Web of Science ®Google Scholar
• Lai TP, Zhang N, Noh J, et al. A method for measuring the distribution of the shortest telomeres in cells and tissues. Nat Commun. 2017;8(1):1356. DOI:10.1038/s41467-017-01291-z
   PubMedGoogle Scholar
• Tham CY, Poon L, Yan T, et al. High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform. Nat Commun, 2023;14(1):281. DOI:10.1038/s41467-023-35823-7
   PubMedGoogle Scholar
• Kirschner M, Vieri M, Kricheldorf K, et al. 2021. Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita. Br J Haematol. 193(3):669–673. doi:10.1111/bjh.16997.
   PubMed Web of Science ®Google Scholar
• Clé D V, Catto LF, Gutierrez-Rodrigues F, et al. Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trial. Haematologica. 2023;108(5):1300–1312. DOI:10.3324/haematol.2022.281808
   PubMed Web of Science ®Google Scholar
• Khincha P P, Bertuch A A, Gadalla S M, et al. Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita. Blood Adv. 2018;2(11):1243–1249. DOI:10.1182/bloodadvances.2018016964
   PubMed Web of Science ®Google Scholar
• Townsley D M, Dumitriu B, Liu D, et al. Danazol Treatment for Telomere Diseases. N Engl J Med. 2016;374(20):1922–31. DOI:10.1056/NEJMoa1515319
   PubMed Web of Science ®Google Scholar
• Grossmann M. Danazol Treatment for Telomere Diseases. N Engl J Med. 2016;375(11):1095. DOI:10.1056/NEJMc1607752
   PubMedGoogle Scholar